Scilex Holding Company SCLX Short-term debt and current portion of long-term debt

Short-term debt and current portion of long-term debt at other companies

Bristol-Myers SquibbBMY

$2.31B-35.1%

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$8.6M+72.1%

Gross profit$4.2M+15.1%

Operating income-$32.2M-15.3%

Net income-$45.7M-75.0%

EPS (diluted)-$6.28-178%

Balance sheet

See full

Cash & equivalents$3.4M-42.2%

Total debt$95.4M+130%

Total equity-$249.2M-17.8%

Total assets$293.6M+272%

Cash flow

See full

Operating cash flow-$1.1M-118%

CapEx$33.3K—

Free cash flow$920.8K-63.7%

Valuation

See full

Market cap$54.86M+88.7%

Enterprise value$146.86M+120%

P/S1.6×+1.0×

Profitability

See full

Gross margin59.7%-12.3pp

Operating margin-1,034.4%-1,313pp

Net margin-1,162.4%-1,359pp

FCF margin12.2%—

Returns & leverage

See full

Return on equity170.9%—

Debt / equity0.3×—

Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:DebtCurrent.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's short-term debt and current portion of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Scilex Holding Company's short-term debt and current portion of long-term debt?: Scilex Holding Company (SCLX) reported short-term debt and current portion of long-term debt of $80.78M in Q1 2026.
How has Scilex Holding Company's short-term debt and current portion of long-term debt changed year-over-year?: Scilex Holding Company's short-term debt and current portion of long-term debt increased by 104.8% year-over-year, from $39.44M to $80.78M.